SDSU Archives - San Diego Biotechnology Connection

Paid life sciences internships, free biotech job-training in San Diego

Biotech-education grants at SDSU available to veterans, others

Stock Daily Change

Biotech Events in San Diego

@SDBiotech

San Diego Biotechnology Connection

Senomyx and Life Sciences Summer Institute, San Diego Biotechnology Connection

February 28, 2012 no comments

San Diego County high school students with good grades and a passion for the life sciences have until March 31 to apply for an unforgettable, paid eight-week life sciences internships this summer in Read More

BRIDGE program, SDSU, San Diego Biotechnology

December 20, 2011 no comments

By Rex Graham The San Diego State University Research Foundation BRIDGE Project currently has grant funding to provide education, training, and employment support services to eligible participants wh Read More

ADMP	0.69	+0.022
AEMD	0.097	-0.008
AHRO	0.73	0.00
AIMM	0.0035	0.00
AMGN	106.22	+1.98
ANX	0.733	0.00
APRI	3.33	-0.08
ARNA	7.96	-0.03
ATEC	1.95	0.00
AVNR	3.315	+0.045
AVTO	0.005	0.00
AXMP	0.015	+0.003
AXRX	0.16	0.00
CADX	6.98	-0.01
CELG	126.45	+2.95
CORX	0.04	0.00
CXM	0.0942	+0.0032
CYTX	2.56	+0.02
CYTR	2.45	+0.03
DRAD	2.42	-0.02
DXCM	21.41	+0.28
ENTB	0.002	0.00
FOLD	3.55	+0.09
HALO	7.63	+0.04
HRBR	0.1887	0.00
IAGXQ	0.14	0.00
ILMN	72.01	-0.57
IMBI	0.028	0.00
ISCO	0.275	-0.025
ISIS	21.15	+0.34
IVRO	0.017	0.00
LGND	28.15	+0.41
LIFE	74.16	+0.48
LJPC	0.076	+0.001
LPTN	4.981	+0.081
MCK	118.79	+0.38
MEDS	1.20	0.00
MEIP	8.48	0.00
MLPH	0.018	0.00
MNKD	6.44	+1.08
MNOV	3.15	-0.03
MRIC	1.15	-0.03
NAII	4.6901	+0.0101
NBIX	12.48	+0.42
NRDCQ	0.0001	0.00
NUXP	0.0016	0.00
ONCS	0.305	-0.0155
OPTR	14.51	+0.08
OREX	6.18	+0.07
PCRX	29.85	+1.01
PFE	29.68	+0.90
QDEL	22.68	+0.03
RHHBY	65.90	+1.19
RMD	50.64	+0.56
SNTS	23.4999	+1.1999
SQNM	4.065	+0.005
TSRX	7.767	-0.003
VOLC	16.98	+0.24
VRX	75.98	+0.45
VRNM	2.1501	+0.0001
VVUS	13.26	+0.10
ZGNX	1.535	+0.015

2013-05-22 11:02

Trius Therapeutics: New, Positive Dimension For Investment Outlook http://t.co/rcVXC57kkN $CBST $TEVA $TSRX
8 days ago
Retweet
@ilus_art Gorgeous way to celebrate art, biology and cells.
17 days ago
Retweet
Trius Therapeutics releases persuasive safety study of potent new antibiotic against MRSA #superbug. http://t.co/uRBiPHj14U
23 days ago
Retweet
Halozyme initiates Phase 2 trial of drug to treat stage 4 pancreatic cancer. http://t.co/U9cjxGbtIL
29 days ago
Retweet
Illumina’s stronger than expected revenue up 21% sends shares up 13%. http://t.co/qviU0MYLQ3
29 days ago
Retweet
Trius presenting clinical-trial results Apr. 27 http://t.co/MCFeBYi57w on tedizolid, a potent MRSA antibiotic. http://t.co/myB421ZD2n
29 days ago
Retweet
After Thermo Fisher Scientific buys Life Technologies, sequencing leader Illumina may finally sell. http://t.co/F92ndBP0z2
37 days ago
Retweet
http://t.co/y8xbsAQ4q8
61 days ago
Retweet
FDA reviewing diabetes drugs causing pancreas precancers. Affected: Lilly, Merck, Novo Nordisk, Bristol-Myers. http://t.co/2dPyRAYLsc
68 days ago
Retweet

23 Events on May 23, 2013 Studies Toward the Synthesis of Antitumor Natural Products Starts: 4:00 pm Ends: May 23, 2013 - 5:00 pm Location: Scripps Research Inst. - Green Hospital Building, Valerie Timken Amphitheater Description: Distinguished Lecture Series Speaker: John A. Porco, Ph.D., Professor, Department of Chemistry, Boston University Read More: <a href="http://pubs.rsc.org/en/content/articlelanding/2013/np/c3np20122h">link</a> More details...

The share price of Trius Therapeutics (TSRX) has rebounded almost fully from its 10 percent dip in the New Year that was triggered by its public offering of 7 million shares; however, uncertainty about the company’s lead investigational drug is a lingering February hangover. Small investors face a dilemma: should they dump their diluted shares, double down? Our story explains why we recommend doubling down: http://sandiegobiotechnology.com/topics/5733/trius-dump-or-double-down-on-maker-of-mrsa-antibiotic/
100 days ago
A Glaxo Smith Kline genital herpes vaccine recently flopped in a large clinical trial, but “next generation” genital herpes vaccines by Genocea Biosciences, Agenus, Inc., and San Diego-based Vical, Inc., offer new hope. http://sandiegobiotechnology.com/topics/5600/glaxo-genital-herpes-vaccine-flops-but-genocea-a-buy-in-vaccine-space/
159 days ago
The Dow was off 1.82 percent, down 243.36 points to 13,102.53 at the close of trading Oct. 23 amid disappointing earnings reports. But 11 publicly traded San Diego biotechs gained for the day. https://sandiegobiotechnology.com/topics/5443/eleven-san-diego-biotech-stocks-rise-amid-tuesday-plunge-in-dow/
210 days ago
Millions of infertile women will soon get the biggest baby boost in a generation from preimplantation genetic diagnosis (PGD), which identifies their healthiest embryos at in vitro fertilization (IVF) clinics. These blastocysts, embryos with 50-150 cells, are at a very favorable stage for implantation and pregnancy. The inner cell mass will give rise to the actual cells of the fetus. The other cells that surround and protect the inner cell mass give rise to the fetal part of the placenta. Photo: Robert Shabanowitz, Gesinger Medical Center
212 days ago
It’s more than a 5-hour energy jolt. Cardium Therapeutics’ purchase of To Go Brands and its nationwide marketing network will give the San Diego biotech company a permanent sales boost for its own nutritional supplements -- and a larger piece of the $30 billion supplements market. https://sandiegobiotechnology.com/topics/5393/cardium-boosts-energy-supplement-sales-with-national-marketing-muscle/
232 days ago